Quantitative analysis for Fortress Biotech, Inc. (FBIO) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Sell (38.0) (grade D). 27 signals analyzed (23 differentiated alt-data).
FBIO stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $2.27 | $2.20 | $2.22 |
| 2026-05-11 | $2.43 | $2.24 | $2.24 |
| 2026-05-21 | $2.79 | $2.68 | $2.78 |
| 2026-06-03 | $2.66 | $2.59 | $2.61 |
| 2026-06-15 | $2.94 | $2.80 | $2.86 |
| 2026-06-26 | $3.04 | $2.70 | $2.76 |
| 2026-07-09 | $3.33 | $3.02 | $3.29 |
| 2026-07-21 | $3.60 | $3.34 | $3.53 |
| 2026-07-31 | $3.28 | $3.08 | $3.13 |
| 2026-08-12 | $2.78 | $2.57 | $2.75 |
| 2026-08-24 | $2.99 | $2.83 | $2.93 |
| 2026-09-03 | $2.76 | $2.70 | $2.71 |
How Fortress Biotech, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| ENGN | enGene Holdings Inc. | $82M | — |
| ONCY | Oncolytics Biotech Inc. | $82M | — |
| OSTX | OS Therapies Incorporated | $82M | — |
| RPID | Rapid Micro Biosystems, Inc. | $91M | — |
View all Health Care stocks by valuation and signals →
Fortress Biotech, Inc. (FBIO) scores Sell (38.0), and the composite conceals a 85-point disagreement between its dimensions. It is strongest on competitive moat at 100 and analyst consensus at 82, and weakest on technicals at 15. A stock can carry competitive moat that high while technicals sits at 15; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 100 |
| analyst consensus | 82 |
| technicals | 15 |
StoQuant analyzes 27 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Fortress Biotech, Inc. (FBIO): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/FBIO"><img src="https://stoquant.com/badge/FBIO.svg" alt="Fortress Biotech, Inc. (FBIO) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.